AMI’s Specialty Pharmacy Database (SPD) includes content relative to all specialty pharmacy stakeholders. This solves the problem of obtaining timely, difficult to obtain business intelligence on specialty pharmacies, including executive contacts with titles, phone numbers and emails, limited distribution drugs dispensed, chronic conditions treated, accreditation(s), services provided, and more.

The database, with 1,325+ pharmacy locations, updates current records and adds new records daily.


Custom Primary Research/Surveys

Customer/Competitor Analysis

Virtual Advisory Board

  • Identify specialty pharmacy decision-makers to connect with key executive to review your products and services.
  • Determine market access and channel strategies to ensure that pharma’s products and services achieve the most optimal access positions.
  • Develop launch strategies for new entities entering the specialty pharmacy market, focusing on the growing number of hospitals and health systems.
  • Develop detailed profiles of specialty pharmacies for competitive analyses and expansion/acquisition/joint venture.
  • Determine if a specialty pharmacy needs to reposition as centers of excellence in key areas of practice.


Market access, trade channel management, marketing and business development, customer account, strategy development, competitor analysis, launch planning and strategy, product and brand directors, pharmacy directors, health plans, infusion pharmacies, hospital and health systems, consultants, among others.

Read the case study

Specialty Pharmacy Database

  • Pharmacy Name
  • URL
  • Street Address
  • City
  • State
  • Zip Code
  • Phone
  • Conditions Treated
  • Company Type
  • Pharmacy Executive
  • Title
  • Contact Email
  • Accreditation(s)
  • Parent/Independent
  • Patient Services
  • Payer Services
  • Pharma Services
  • Health Plan Preferred Contract(s)
  • Locations
  • Limited Distribution Drugs
  • Unique Pharmacy Identifier
  • Date Record Added/Modified
View Sample Data

Updated 11/16/21


License Agreement

Delivery of the Data — Clients will receive an excel spreadsheet for their use only (see sample above). Subscribers will receive the full database updated monthly.

Raising the Stakes for Market Access Support by John Santilli, AMI

The biopharmaceutical drug pipeline focuses on specialty drugs and rare diseases. Today, specialty pharmacy drugs are more often available in a dosage form that patients can administer themselves, such as a tablet, capsule, pill, patch or subcutaneous injection. As specialty pharmacy continues to grow rapidly, it has become an essential assessment for industry stakeholders…

Interested in learning more about the database, requesting the specific data you need, or discussing a custom research project?

Yes! Please contact me at:

  • This field is for validation purposes and should be left unchanged.

Learn More

AMI’s new report, Specialty Pharmacy Market Leaders 2022 Overview, includes background on the industry and also provides company profiles of each pharmacy. Many specialty pharmacies operate independently although the market leaders are often owned by parent entities such as pharmacy benefit managers (PBMs), retail pharmacy and food chains, distributors, health plans, and increasingly, hospitals and health systems.

Learn More

AMI’s Specialty Hub Services Providers 2021 Report has expanded to include more than 60 Hub services providers. The report includes comprehensive information on providers’ solutions and services as industry stakeholders are increasingly interested in identifying the expertise offered by market participants. Based on customer feedback, this year’s report also includes a deeper dive on each company’s executive leadership as well as including financial and/or investor information.